Skip to market wire
InvestLog
Back to Market返回行情

SLBT SL Science Holding Ltd

NASDAQHealthcare
$1.60-5.88%ClosedMarket Cap: $897.2M

As of 2026-10-01

Why SLBT matters now

SL Science Holding Ltd (SLBT) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.60 with -5.88% on the session and $897.2M in market capitalization.

The latest indexable market news headline is "SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma" from GlobeNewsWire.

Latest News

SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant GlioblastomaGlobeNewsWire · 2026-09-24
SL Science: A $1.15 Billion Valuation Built On Preclinical PromisesSeeking Alpha · 2026-09-16
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded CompanyGlobeNewsWire · 2026-09-02
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its PlatformGlobeNewsWire · 2026-08-27
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in GlioblastomaGlobeNewsWire · 2026-08-11

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

Beta

0.09

Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York.